Thank you for subscribing. We will take note of your stated preferences and be in touch accordingly.
Gamifant is the first FDA-approved treatment specifically developed for primary hemophagocytic lymphohistiocytosis (HLH), targeting interferon gamma (IFNγ) overexpression.1
How to access Gamifant for your patients
Gamifant is available for order via our specialty pharmacy or through one of our two specialty distributors.
McKesson Plasma and Biologics
McKesson Specialty Health
Gamifant is supplied in
10 mg/2 mL and 50 mg/10 mL single-use glass vials.
Please note that the patient's insurance coverage may dictate how Gamifant should be ordered.
10 mg/2 mL (5 mg/mL)
50 mg/10 mL (5 mg/mL)
To better understand your patient's benefits please contact Sobi Patient Services at 833.597.6530.Download product fact sheet
Sign up to stay informed!
Receive updates on Gamifant news and information.
*Indicates required field